Meet the leader of the Rogel Cancer Center's Community Outreach & Engagement Program

In early 2026, Rachel Bergmans, Ph.D., MPH, was named as administrative director of the COE team.

The Rogel Cancer Center’s Community Outreach and Engagement team has a strong focus on meeting cancer awareness needs and education throughout the State. 

In early 2026, Rachel Bergmans, Ph.D., MPH, was named as administrative director of the COE team. We sat down to get to know her better and what her goals are in her new role.

What brought you to the Rogel Cancer Center’s Community Outreach and Engagement team? 

I was drawn to COE because of its mission to advance health equity, foster community partnership, and create measurable impact across Michigan. My career has been shaped by interdisciplinary collaboration in public health, and I’m excited to contribute to Rogel’s efforts in reducing cancer disparities and building relationships statewide.

How would you describe your professional journey before joining COE? 

My background is in epidemiology and public health, with research spanning integrative medicine, social determinants of health, chronic pain, mental wellbeing, and community engaged science. I’ve worked across a variety of environments, from academic collaborations in Madison, Wisconsin, and Ann Arbor, Michigan, participatory programs with veterans and lupus advocates, to educational and health-focused initiatives in Thailand and Zambia.

What motivates you in your work? 

I’m motivated by the opportunity to connect people and ideas across disciplines, and by helping center lived experience in research and outreach. I believe meaningful impact is built through clear vision, data-driven approaches, shared metrics of success, and valuing diverse perspectives.

What are your goals for your first few months at COE? 

My main goal is to listen and learn from the team and our partners, understand COE’s strengths and opportunities, and build a foundation for collaboration. I want to help address immediate community concerns, support authentic partnerships between researchers and individuals with lived experience, and lay the groundwork for our next phase of growth.

What do you enjoy outside of work? 

Outside of work, I enjoy practicing yoga, creative writing, and spending time outdoors. I’m inspired by storytelling, both through health research and in everyday life.

Learn more about Dr. Bergmans by listening to the Chronic Pain Reset Podcast, episode 58:  Better Together, A Community Based Approach.


More Articles About:

Rogel Cancer Center

In This Story

Rachel Bergmans

Rachel S Bergmans, MPH, PhD

Research Assistant Professor

Featured News & Stories

couple with 3 dogs on porch smiling
Health Lab

Receiving personalized treatment for a rare neuroendocrine tumor

Danielle Schuldt was diagnosed with a rare endocrine tumor and underwent surgery as part of her treatment. She now undergoes regular surveillance to monitor for cancer recurrence.
woman touching her neck in robe at home
Health Lab

Phase 1 trial of alrizomadlin shows promise in targeting metastatic salivary gland cancers

University of Michigan researchers, in partnership with Ascentage Pharma, developed a drug known as alrizomadlin, or APG-115, to target metastatic salivary gland cancers.
big microscope two scientist holding with green background
Health Lab

New dual-target drug may help overcome immunotherapy resistance in pancreatic cancer

U-M researchers developed a new strategy to improve immunotherapy treatments for pancreatic cancer.
Cancer Aware surrounded by a circle of multicolor ribbons
Cancer Aware

CAR T-cell Therapy

Using one's cells to attack and treat cancer continues to grow. Cellular therapy and in particular CAR T-cell therapy offers new opportunities to adult and pediatric patients with blood cancers like leukemia and lymphoma. Dr. Monalisa Ghosh, Rogel Cancer Center oncologist talks about these treatments and and the future of cellular therapy.
Man in a blue pullover against the background of Michigan Stadium
Health Lab

Thriving after a rectal cancer diagnosis

Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.
treatment choices finding a doctor team approach clinical trial pancreatic cancer diagnosis plan A genetics
Health Lab

Diagnosed with pancreatic cancer: Now what?

A pancreas cancer surgeon explains from Michigan Medicine how to find the best place for treatment, why that matters, and what to expect from the process.